Rheumatology International

, Volume 25, Issue 3, pp 195–200 | Cite as

Calcaneus bone mineral density in Japanese women with rheumatoid arthritis

  • S. DoiEmail author
  • K. Kushida
  • S. Miyamoto
  • Y. Sekioka
  • M. Suzuki
  • T. Inoue
  • A. Nagano
Original Article



The aim of this study was to investigate the relationships among bone mineral densities (BMD) in the calcaneus and leg activity of daily living (L-ADL) in rheumatoid arthritis (RA) patients.


We measured and compared calcaneus BMD using single X-ray absorptiometry and lumbar spine and femoral neck BMD using dual X-ray absorptiometry in 158 Japanese female outpatients with RA and 358 normal controls (NC).


Regardless of whether the women were premenopausal or postmenopausal, calcaneus and femoral neck BMDs in the RA group were significantly lower than in the NC group. Calcaneus BMD correlated with the modified health assessment questionnaire, L-ADL score, and 10-m walking time, regardless of whether the patients were premenopausal or postmenopausal (P<0.01).


We conclude that calcaneus BMD reflects the L-ADL of RA patients very well and allows us to perform the same level of BMD evaluation as that with current BMD measurement methods.


Bone mineral density Calcaneus Rheumatoid arthritis Single X-ray absorptiometry 


  1. 1.
    Christiansen C, Rodbro P (1975) Skeletal status in patients with rheumatoid arthritis. Acta Med Scand 198:453–454PubMedGoogle Scholar
  2. 2.
    Hahn TJ, Hahn BH (1976) Osteopenia in patients with rheumatic disease: principles of diagnosis and therapy. Semin Arthritis Rheum 6:165–188PubMedGoogle Scholar
  3. 3.
    Sambrook PN, Ansell BM, Foster S, Gumpel JM, Hesp R, Reeve J (1985) Bone turnover in early rheumatoid arthritis. Two longitudinal bone density studies. Ann Rheum Dis 44:580–584PubMedGoogle Scholar
  4. 4.
    Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S (1987) Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 30:721–728PubMedGoogle Scholar
  5. 5.
    Laan R, Buijs W, Draad M et al (1991) Bone mineral density in rheumatoid arthritis: influence of disease activity and functional capacity. Arthritis Rheum 34:S180Google Scholar
  6. 6.
    Nancy EL, Pressman AR, Star VL, Cummings SR, Nevitt MC, Study of Osteoporotic Fractures Research Group (1995) Rheumatoid arthritis and bone mineral density in elderly women. J Bone Min Res 10:257–263Google Scholar
  7. 7.
    Hooyman JR, Meiton LJ, Nelson AM, O’Fallon WM, Riggs BL (1984) Fractures after rheumatoid arthritis. Arthritis Rheum 27:1353–1361PubMedGoogle Scholar
  8. 8.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedGoogle Scholar
  9. 9.
    Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662Google Scholar
  10. 10.
    Katagiri H (1994) Bone mineral measurement of the calcaneus by single X-ray absorptiometry. Nippon-Seikeigeka-Gakkai-Zassi 68:1044–1055Google Scholar
  11. 11.
    Sekioka Y, Kushida K, Yamazaki K, Inoue T (1999) Calcaneus bone mineral density using single X-ray absorptiometry in Japanese women. Calcif Tissue Int 65:106–111CrossRefPubMedGoogle Scholar
  12. 12.
    Lansbury J (1968) Clinical appraisal of the activity index as a measure of rheumatoid activity. Arthritis Rheum 11:599–604PubMedGoogle Scholar
  13. 13.
    Pincus T, Summey JA, Sopaci SA, Wallston KA, Hummon NP (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire. Arthritis Rheum 26:1346–1353PubMedGoogle Scholar
  14. 14.
    Vogel JM, Wasnich RD, Ross PD (1988) The clinical relevance of calcaneus bone mineral measurements: a review. Bone Miner 5:35–58PubMedGoogle Scholar
  15. 15.
    Muller MN, Jurist JM (1973) Skeletal status in rheumatoid arthritis: a preliminary report. Arthritis Rheum 16:66–70PubMedGoogle Scholar
  16. 16.
    Oka M, Rekonen A, Kuikka J, Anttinen J (1975) Bone mineral density in rheumatoid arthritis measured by the gamma transmission method. Scand J Rheumatol 4:28–32PubMedGoogle Scholar
  17. 17.
    Duncan H, Forst HM, Villanueva AR, Sigler JW (1965) The osteoporosis of rheumatoid arthritis. Arthritis Rheum 3:943–954Google Scholar
  18. 18.
    Saville PD, Kharmosh O (1967) Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroid. Arthritis Rheum 10:423–430PubMedGoogle Scholar
  19. 19.
    Kenndy AC, Lindsay R (1977) Bone involvement in rheumatoid arthritis. Clin Rheum Dis 3:403–420Google Scholar
  20. 20.
    Wordsworth BP, Vipod S, Woods CG, Mowat AG (1984) Metabolic bone disease among in patients with rheumatoid arthritis. Br J Rheumatol 23:251–257PubMedGoogle Scholar
  21. 21.
    Sambrook PN, Eisman JA, Champion GD, Pocock NA (1988) Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 31:973–978PubMedGoogle Scholar
  22. 22.
    Laan R, van Riel P, van Erning L, Lemmens J, Ruijs S, van de Putte L (1992) Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheumatol 31:91–96PubMedGoogle Scholar
  23. 23.
    Reid DM, Kennedy NSJ, Smith MA, Tothill P, Nuki G (1982) Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J 285:330–332Google Scholar
  24. 24.
    Als OS, Gotfredsen A, Christiansen C (1983) Relationship between local and total bone mineral in patients with rheumatoid arthritis and normal subjects. Clin Rheumatol 2:265–271PubMedGoogle Scholar
  25. 25.
    Verstraeten A, Dequeker J (1986) Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis 45:852–857PubMedGoogle Scholar
  26. 26.
    Sambrook PN, Eisman JA, Yeates MG, Pocock NA, Eberl S, Champion GD (1986) Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis 45:950–953PubMedGoogle Scholar
  27. 27.
    Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG (1989) Effects of low dose corticosteroids on bone mass in rheumatoid arthritis. Ann Rheum Dis 48:535–538Google Scholar
  28. 28.
    Hajiroussou VJ, Webley M (1984) Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. Ann Rheum Dis 43:24–27PubMedGoogle Scholar
  29. 29.
    The Research Sub-Committee of the Empire Rheumatism Council (1960) Gold therapy in rheumatoid arthritis. Ann Rheum Dis 19:95–119PubMedGoogle Scholar
  30. 30.
    Lidsky MP, Sharp JT, Billings S (1973) Double blind study of cyclophosphamide in rheumatoid arthritis. Arthritis Rheum 16:148–153PubMedGoogle Scholar
  31. 31.
    Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCrum WR (1974) Gold salts in the treatment of rheumatoid arthritis: a double-blind study. Ann Int Med 80:21–26PubMedGoogle Scholar
  32. 32.
    Deluca HF (1979) Vitamin D, metabolism and function. Springer, Berlin Heidelberg New York, pp 1–61Google Scholar
  33. 33.
    Abe E, Miyaura C, Sakagami H et al (1981) Differentiation of mouse myeloid leukemia cells induced by 1α,25(OH)2D3. Proc Natl Acad Sci U S A 78:4990–4994PubMedGoogle Scholar
  34. 34.
    Pullar T, Hunter JA, Capell HA (1984) Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis 43:18–23PubMedGoogle Scholar
  35. 35.
    Ott SM, Chesnut CH III (1989) Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 110:267–274PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • S. Doi
    • 1
    Email author
  • K. Kushida
    • 1
  • S. Miyamoto
    • 1
  • Y. Sekioka
    • 1
  • M. Suzuki
    • 1
  • T. Inoue
    • 1
  • A. Nagano
    • 1
  1. 1.Department of Orthopaedic SurgeryHamamatsu University School of MedicineShizuoka 431-3192Japan

Personalised recommendations